Transaction · 0000950170-25-023311

Chi Jeffrey

Chi Jeffrey, DIR, reported a transaction classified as C at Aardvark Therapeutics, Inc. involving 133364.000000 shares. Reported holdings after the transaction were 133364.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

CSEC transaction code CDIR
AARDAardvark Therapeutics, Inc.
Filing timeFeb 19
Trade dateFeb 14, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

AARD price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
AARD since 2025-02-19Filed 561 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
C
Code C
Identifier
0000950170-25-023311
Common Stock
Transaction date
Feb 14, 2025
Filed Feb 19, 2025, 09:57 PM · 5d delay
Shares
133k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
133k sh
Indirect · By Vickers Venture Co-investment LLC

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Large Holdings Increase
-8score
Filing-only score

-8

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The Series C Convertible Preferred Stock of Aardvark Therapeutics, Inc. (the "Issuer") automatically converted on an 8.474-for-1 basis into shares of the Common Stock immediately prior to the closing…

  2. F2

    Vickers Venture Co-investment LLC ("Vickers Co-investment") is managed by Vickers Venture Partners (S) Pte. Ltd. which is in turn managed by its directors, being Dr. Jeffrey Chi and Dr. Finian Tan, wh…

Original filing · 0000950170-25-023311
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

AARD